Does TORIPALIMAB Cause Neutrophil count decreased? 67 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 67 reports of Neutrophil count decreased have been filed in association with TORIPALIMAB (LOQTORZI). This represents 5.0% of all adverse event reports for TORIPALIMAB.
67
Reports of Neutrophil count decreased with TORIPALIMAB
5.0%
of all TORIPALIMAB reports
0
Deaths
25
Hospitalizations
How Dangerous Is Neutrophil count decreased From TORIPALIMAB?
Of the 67 reports, 25 (37.3%) required hospitalization, and 11 (16.4%) were considered life-threatening.
Is Neutrophil count decreased Listed in the Official Label?
Yes, Neutrophil count decreased is listed as a known adverse reaction in the official FDA drug label for TORIPALIMAB.
What Other Side Effects Does TORIPALIMAB Cause?
Myelosuppression (590)
Off label use (276)
White blood cell count decreased (144)
Anaemia (67)
Hypothyroidism (67)
Nausea (60)
Rash (59)
Vomiting (58)
Platelet count decreased (53)
Diarrhoea (50)
What Other Drugs Cause Neutrophil count decreased?
CLOZAPINE (2,523)
LENALIDOMIDE (2,471)
PALBOCICLIB (2,224)
CYCLOPHOSPHAMIDE (1,985)
CARBOPLATIN (1,734)
PACLITAXEL (1,562)
RITUXIMAB (1,509)
DEXAMETHASONE (1,320)
BEVACIZUMAB (1,225)
POMALIDOMIDE (1,062)
Which TORIPALIMAB Alternatives Have Lower Neutrophil count decreased Risk?
TORIPALIMAB vs TORSEMIDE
TORIPALIMAB vs TOVIAZ
TORIPALIMAB vs TOVORAFENIB
TORIPALIMAB vs TOZINAMERAN
TORIPALIMAB vs TRABECTEDIN